A clear association between the higher mRNA expression level of ENO1, MMP-2 and MMP-9 with a worse prognosis was already detected, suggesting that the elevated ENO1 and MMPs are promising biomarkers for breast cancer. Here, MMP2 is linked to breast carcinoma.